PITX2 and β-Catenin Interactions Regulate Lef-1 Isoform Expression by Melanie Amen et al.
MOLECULAR AND CELLULAR BIOLOGY, Nov. 2007, p. 7560–7573 Vol. 27, No. 21
0270-7306/07/$08.000 doi:10.1128/MCB.00315-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
PITX2 and -Catenin Interactions Regulate Lef-1 Isoform Expression
Melanie Amen,1 Xiaoming Liu,2 Usha Vadlamudi,3 Gabriela Elizondo,4 Evan Diamond,1
John F. Engelhardt,2 and Brad A. Amendt1*
Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas1; Department of Anatomy and
Cell Biology, University of Iowa College of Medicine, Iowa City, Iowa2; Department of Biological Science, The University of
Tulsa, Tulsa, Oklahoma3; and Escuela de Medicina, Tecnologico De Monterrey, Monterrey, Mexico4
Received 21 February 2007/Returned for modification 9 May 2007/Accepted 20 August 2007
Lef-1 and PITX2 function in the Wnt signaling pathway by recruiting and interacting with -catenin to
activate target genes. Chromatin immunoprecipitation (ChIP) assays identified the Lef-1 promoter as a PITX2
downstream target. Transgenic mice expressing LacZ driven by the 2.5-kb LEF-1 promoter demonstrated
expression in the tooth epithelium correlated with endogenous Lef-1 FL epithelial expression. PITX2 isoforms
regulate the LEF-1 promoter, and -catenin synergistically enhanced activation of the LEF-1 promoter in
combination with PITX2 and Lef-1 isoforms. PITX2 enhances endogenous expression of the full-length
-catenin-dependent Lef-1 isoform (Lef-1 FL) while decreasing expression of the N-terminally truncated
-catenin-independent isoform. Our research revealed a novel interaction between PITX2, Lef-1, and -cate-
nin in which the Lef-1 -catenin binding domain is dispensable for its interaction with PITX2. PITX2 interacts
with two sites within the Lef-1 protein. Furthermore, -catenin interacts with the PITX2 homeodomain and
Lef-1 interacts with the PITX2 C-terminal tail. Lef-1 and -catenin interact simultaneously and independently
with PITX2 through two different sites to regulate PITX2 transcriptional activity. These data support a role for
PITX2 in cell proliferation, migration, and cell division through differential Lef-1 isoform expression and
interactions with Lef-1 and -catenin.
Pitx2 and Lef-1 encode two transcription factors whose ex-
pression can be regulated by early signaling events involved in
numerous developmental programs. Pitx2 and Lef-1 are differ-
entially expressed in many tissues, and they demonstrate over-
lapping expression during tooth development. Lef-1 can be
activated by BMP, Wnt, Smads, and transforming growth fac-
tor  signaling (18, 32, 33). Furthermore, Lef-1 transcriptional
activity is regulated by its interaction with -catenin. Secreted
Wnt proteins initiate a signaling cascade that prevents degra-
dation of -catenin in the cytoplasm, and -catenin subse-
quently translocates to the nucleus, where it activates Wnt-
responsive genes (42). The full-length Lef-1 (Lef-1 FL)
isoform, containing the -catenin binding domain (BD) has
been termed growth promoting because it is expressed during
cell growth in undifferentiated, mitotically active cells. This
Lef-1 activity is countered by the expression of a truncated
Lef-1 protein that lacks the BD and can compete for binding
to Wnt target genes. This shorter Lef-1 transcript (Lef-1
N113) could act as an inhibitory isoform, due to its ability to
interact with cofactors that also bind Lef-1 FL, as well as
compete for DNA binding sites, and thus has been termed
growth suppressing (27, 30, 34). However, both Lef-1 isoforms
can stimulate cell differentiation. Interestingly, in colon cancer
cells, only the LEF-1 FL transcript is produced, and the loss of
balance between the long and short forms may affect cancer
progression (30, 34). Therefore, it is essential to understand
the molecular functions of these two Lef-1 isoforms.
Tooth development is initiated with a thickening of the ec-
toderm-derived oral epithelium between embryonic day 10
(E10) and E11. The epithelium undergoes invagination into
the neural crest-derived mesenchyme to form a tooth “bud.”
The bud forms at E12, and at E13, the enamel knot forms
at the base of the tooth bud and comprises a signaling center
driving tooth morphogenesis. A role for Lef-1 in the develop-
ment of teeth, whiskers, hair follicles, and mammary glands
was identified through targeted inactivation of the Lef-1 gene
in mice (43). In Lef-1 mutant mice, tooth development is ar-
rested at later stages, and the mice lack teeth. Consistent with
this phenotype, Lef-1 expression can be seen at E10.5 in the
dental epithelium, and at E14.5 during cap stage development,
Lef-1 was found in both the dental epithelium and dental
papilla mesenchyme (40, 43). From E10 to E12, Lef-1 tran-
scripts are detected initially in the epithelium and subsequently
in the mesenchyme, consistent with the change in the devel-
opmental dominance of these tissues (34). The role of Lef-1 in
the mesenchyme is unclear, since an essential function for
Lef-1 expression could be demonstrated only in the dental
epithelium between E13 and E14, corresponding to the pres-
ence of Lef-1 transcripts in the epithelial tooth bud (34).
Pitx2 is the earliest transcription marker observed in tooth
development and is specifically restricted to the developing
dental epithelium (24, 39). In tooth formation, as in all organs,
developmental programs are usually initiated by more than
one gene and cell type acting in concert to promote cell pro-
liferation, migration, and/or differentiation. Tooth develop-
ment is arrested in Pitx2/ mice (19, 35, 37). -catenin is
expressed at the same time as Lef-1 and Pitx2 in the developing
tooth bud and epithelial tissues (17).
In order to understand the roles of PITX2, -catenin, and
Lef-1 in tooth and other developmental pathways, we analyzed
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transgenic mice expressing LacZ under the control of the
LEF-1 promoter. This construct demonstrated expression in
the dental epithelium at an early stage (E12.5) of tooth devel-
opment. The expression of LEF-1 directly overlaps Pitx2 and
occurs at approximately E1.5 after Pitx2 expression. Thus, the
human LEF-1 promoter can recapitulate endogenous Lef-1
expression in the dental epithelium. PITX2 induces Lef-1 FL
expression in CHO cells, which do not endogenously express
this Lef-1 isoform. Our data reveal -catenin-dependent and
-independent Lef-1 transcriptional activities and interactions
with PITX2 to regulate Lef-1 expression. Lef-1 interactions
with PITX2 provide a feedback mechanism that allows the
continued expression of Lef-1. Changes in Lef-1 expression to
the Lef-1 FL -catenin-dependent isoform correlates with its
activity in cell division, migration, and morphogenesis. Pitx2
expression is linked to cell division, migration, and morpho-
genesis, and the coordinated expression of these factors is
required for normal embryonic development and provides a
new mechanism for the control of these events.
MATERIALS AND METHODS
ChIP analysis. Chromatin immunoprecipitation (ChIP) analysis was per-
formed as described using the ChIP assay kit (Upstate) and as previously de-
scribed (11). Two primers for amplifying the PITX2 binding site in the Lef-1
proximal promoter were as follows: sense, starting at 1049 (5-AGACAGTG
GGAACCGGAGAA-3), and antisense, starting at 668 (5-ACTCTACTAA
CCGTGAATCACAC-3). Two primers for amplifying the PITX2 binding site in
the Lef-1 distal promoter were as follows: sense, starting at 5657 (5-GGAG
GAGGGCATCAGATCTTATTGTGAGTGGTTG-3), and antisense, starting
at 5245 (5-TTAGGAGGCAAGGTACATATTTAAGGGGGAGAG-3). All
the PCR products were evaluated on a 2% agarose gel in 1 Tris-borate-EDTA
for appropriate size and confirmed by sequencing. As controls, the Lef-1 primers
were used without chromatin, normal rabbit immunoglobulin G (IgG) was used
to replace the PITX2 antibody to reveal nonspecific immunoprecipitation (IP) of
the chromatin, and primers for an unrelated gene were used to demonstrate the
specificity of the PITX2 antibody-immunoprecipitated chromatin.
Lef-1 promoter-reporter constructs and the generation of transgenic mice. As
previously described, the LEF-1 expression construct (LF-2700/-200) containing
the human LEF-1 promoter fragment upstream of the -galactosidase gene (18)
was used to generate previously characterized transgenic mice (18). LF-2700/-200
contains sequences in the promoter that span bp 2700 to 200 (relative to the
ATG start methionine at 1). Transgenic mice were genotyped by PCR and/or
Southern blotting using DNA prepared from tail biopsy specimens. Primer sets
EL905 (5CAAACTTCAGCTTCCCTTCTGCTG) and EL906 (5 GACGAGG
AAGAAGGAACTGAAGAC) were derived from a -galactosidase transgene
and used for PCR screening. These primers identified a 379-bp -galactosidase
transgene band in positive transgenic mice.
Histochemical detection of -galactosidase activity. Timed pregnancies were
established between C57BL/6J males and heterozygous, transgene-positive fe-
males. The appearance of a vaginal plug on the morning following breeding was
designated as E0.5. PCR of DNA harvested from the yolk sac or part of the
embryo determined the genotypes of the embryos. Embryos and/or tissue sam-
ples were dissected in cold phosphate-buffered saline (PBS) at designated ages
and fixed (0.2% glutaraldehyde, 5 mM EGTA, pH 7.3, 2 mM MgCl2, 0.02%
NP-40, 0.01% deoxycholate, 2% paraformaldehyde, 0.1 M sodium phosphate,
pH 8.8) for 15 to 60 min at room temperature with rocking. After being washed
in detergent solution (0.02% NP-40, 0.01% deoxycholate, 2 mM MgCl2 in 0.1 M
sodium phosphate, pH 8.0) three times for 10 min each time at room tempera-
ture, the embryos were stained with X-Gal (5-bromo-4-chloro-3-indolyl--D-
galactopyranoside) solution (1 mg/ml X-Gal, 5 mM potassium ferricyanide, and
5 mM potassium ferrocyanide in the wash buffer) in the dark at 37°C for 3 h.
They were then incubated at room temperature overnight. The stained embryos
were postfixed in 0.5% glutaraldehyde-10% formalin after being washed three
times in PBS. The embryos were equilibrated in 80% glycerol-PBS (containing
0.5% Triton X-100) prior to being photographed. When histologic sections were
evaluated, the embryos were equilibrated in 30% sucrose and embedded in
optimal-cutting-temperature compound. Sections were counterstained with pro-
pidium iodide prior to being photographed.
In situ hybridization. The mouse PITX2C full-length cDNA and the proline-
rich region (450 bp) of the mouse Lef-1 cDNA (GenBank accession no. 6754531)
were cloned into a pBlueScript KS plasmid (Stratagene, La Jolla, CA) using
KpnI and EcoRV restriction sites. This region does not overlap with conserved
high-mobility group (HMG) DNA binding domains. The sense and antisense
digoxigenin-labeled RNA probes were prepared by in vitro transcription using a
digoxigenin-RNA labeling kit with T3 and T7 RNA polymerase in accordance
with the manufacturer’s instructions (Roche Molecular Systems, Pleasanton,
CA). Whole-mount hybridization was performed essentially as previously de-
scribed (25, 44); however, a higher temperature (70°C) was employed during the
hybridization and washing steps. In situ hybridizations on cryosections were
performed as previously described (13–15) with the above-mentioned digoxigenin-
labeled RNA probes.
Immunohistochemistry. Mouse embryos were treated with 4% paraformalde-
hyde and dehydrated with sequential concentrations of alcohol and finally with
xylene. Then, the embryos were embedded in paraffin, and sections were made
at 5-m thickness. The sections were deparaffinized and treated with 0.1 M
sodium citrate buffer for 7.5 min at 100% power in a revolving 800-W microwave
with an additional three cycles of 5 min at 50% power. Subsequently, the sections
were treated with 4% hydrogen peroxide to block the endogenous peroxidase
activity. Then, the slides were incubated with 5% goat serum for 30 min, followed
by overnight incubation with anti--catenin antibody at 1/400 dilution (Chemicon
International). The following day, the slides were treated with biotinylated anti-
rabbit secondary antibody (Vector Laboratories) at a concentration of 1/200 for
30 min. Avidin biotin complex and DAB substrate (Vector Laboratories) were
used as our reporting system. Negative controls were treated exactly the same
except for the primary antibody; PBS with 5% blocking goat serum was used.
Expression and reporter constructs. Expression plasmids containing the cyto-
megalovirus (CMV) promoter linked to the PITX2 cDNA were constructed in
pcDNA 3.1 MycHisC (Invitrogen) (1, 2, 9). Lef-1 and -catenin S37A expression
plasmids have been previously described (18). Lef-1 deletion clones were made
using nested primers and cloned into the pcDNA 3.1 MycHisC vector. The Lef-1
deletion constructs were prepared by PCR amplification of the full-length Lef-1
cDNA and cloned into the pcDNA3.1 MycHisC vector. The human LEF-1
promoters have been previously described and were PCR amplified and cloned
into the luciferase vector as previously described (41). All constructs were con-
firmed by DNA sequencing. A simian virus 40 (SV-40) or CMV -galactosidase
reporter plasmid was cotransfected in all experiments as a control for transfec-
tion efficiency. All plasmids were double-banded CsCl purified.
Western blot assays. Expression of endogenous or transiently expressed
PITX2, Lef-1, and -catenin proteins was demonstrated using the PITX2 P2R10
antibody (24) and Lef-1 and -catenin antibodies (Upstate). The Lef-1 mouse
monoclonal antibody from Upstate recognizes the 57- to 55-kDa proteins, as well
as the short isoform. Approximately 10 to 40 g of transfected cell lysates were
analyzed in Western blots. Following SDS gel electrophoresis, the proteins were
transferred to polyvinylidene difluoride (PVDF) filters (Millipore), immuno-
blotted, and detected using specific antibodies and enhanced-chemiluminescence
(ECL) reagents from GE HealthCare.
Cell culture, transient transfections, and luciferase and -galactosidase as-
says. CHO, C3H10T1/2, and LS-8 cells were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 5% or 10% fetal bovine serum and penicil-
lin/streptomycin and transfected by electroporation. The cultures were fed 24 h
prior to transfection, resuspended in PBS, and mixed with 2.5 g of expression
plasmids, 5 g of reporter plasmid, and 0.5 g of CMV or SV-40 -galactosidase
plasmid. Electroporation of CHO cells was performed at 360 V and 950 F
(Gene Pulser XL; Bio-Rad) and that of C3H10T1/2 cells at 380 V and 950 F.
LS-8 cells were transfected by electroporation as previously described (22). The
transfected cells were incubated for 24 h in 60-mm culture dishes and fed with
5% fetal bovine serum and Dulbecco’s modified Eagle’s medium and then lysed
and assayed for reporter activities and protein content by Bradford assay (Bio-
Rad). Luciferase was measured using reagents from Promega. -Galactosidase
was measured using the Galacto-Light Plus reagents (Tropix Inc.). All luciferase
activities were normalized to -galactosidase activity.
Expression and purification of glutathione S-transferase (GST) fusion pro-
teins. The human PITX2A and -C constructs were PCR amplified from cDNA
clones as described previously (1, 2). The PITX2, -catenin, and Lef-1 PCR
products were cloned into the pGex6P2 GST vector (Amersham Pharmacia
Biotech) as previously described (1, 2). All pGex6P-2 GST plasmids were con-
firmed by DNA sequencing. The plasmids were transformed into BL21 cells.
Proteins were isolated as described previously (2, 9). All proteins were cleaved
from the GST moiety with PreScission protease (GE HealthCare). Protein con-
centrations were quantitated with Bradford Reagent (Bio-Rad Laboratories,
Hercules, CA). Proteins were examined by electrophoresis on denaturing SDS-
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polyacrylamide gels, followed by Coomassie blue staining (50% methanol, 10%
acetic acid, and 0.5% Coomassie brilliant blue stain).
GST-PITX2 pull-down assays. Immobilized GST–Lef-1 and GST-PITX2 fu-
sion proteins were prepared as described above and suspended in binding buffer
(20 mM HEPES, pH 7.5, 5% glycerol, 50 mM NaCl, 1 mM EDTA, 1 mM
dithiothreitol with or without 1% milk and 400 g/ml of ethidium bromide).
Purified bacterially expressed PITX2, -catenin, or Lef-1 protein (80 to 100 ng)
was added to 5 g immobilized GST–Lef-1, GST-PITX2, or truncated fusion
proteins or GST, respectively, in a total volume of 100 l and incubated for 30
min at 4°C. The beads were pelleted and washed four times with 200 l binding
buffer. The bound proteins were eluted by boiling them in SDS sample buffer and
separated on either 10% or 12.5% SDS-polyacrylamide gels or 15% tricine gels.
The experiment to analyze cobinding of -catenin and Lef-1 N113 to PITX2
was performed by adding purified -catenin and Lef-1 N113 to the appropriate
GST-PITX2 constructs. After incubation and extensive washing, the beads were
divided into aliquots, run on an SDS gel, and probed with either -catenin or
Lef-1 antibodies. Thus, both Lef-1 N113 and -catenin were present in the
binding reactions. Purified PITX2C, -catenin, or Lef-1 protein was analyzed in
a Western blot. Following SDS gel electrophoresis, the proteins were transferred
to PVDF filters (Millipore), immunoblotted, and detected using the PITX2,
-catenin, or Lef-1 antibody (Upstate) and ECL reagents from GE HealthCare.
RT-PCR. CHO cells were transfected with empty expression vector (mock) or
pCMV-PITX2C, and cells were harvested 48 h after transfection. Total RNA was
isolated as previously described (41). Reverse transcription was preformed using
5 g of total RNA, random primers, iScript reverse transcriptase (RT), and
the iScript Select cDNA synthesis kit (Bio-Rad) in a total volume of 20 l. The
reaction mixture was incubated according to the manufacturer’s directions. The
cDNA (2 l) was used in the PCR with Advantage polymerase (Clontech) and
the appropriate primers. The sense primer for amplification of the Lef-1 FL
isoform was 5-GCAGCGGAGCGGAGATTACACAG-3, and the antisense
primer was 5-TCCCTTGTTGTACAGGCCTCCGTC-3. The primer pair for
the Lef-1 short isoform was 5-CGGCGTTGGACAGATCAC-3 (sense) and
5-TTGATAGCTGCACTCTCC-3 (antisense). Products were analyzed on an
agarose gel, and bands were isolated and sequenced to confirm their identities.
IP assay. Approximately 24 h after cell transfection with PITX2 and Lef-1 FL,
CHO cells were rinsed with 1 ml of PBS and then incubated with 1 ml ice-cold
RIPA buffer for 15 min at 4°C. Cells were harvested and disrupted by repeated
aspiration through a 25-gauge needle attached to a 1-ml syringe. The lysates were
then incubated on ice for 30 min. Cellular debris was pelleted by centrifugation
at 10,000  g for 10 min at 4°C. An aliquot of lysate was saved for analysis as an
input control. The supernatant was transferred to a fresh 1.5-ml microcentrifuge
tube on ice and precleared using the mouse ExactaCruz C IP matrix (Santa Cruz
Biotechnology) for 30 m at 4°C. The matrix was removed by brief centrifugation,
and the supernatant was transferred to a new tube. An IP antibody-IP matrix
complex was prepared according to the manufacturer’s instructions, using pri-
mary anti-Lef-1 (1.7 l) antibody (Upstate). The IP antibody-IP matrix complex
was incubated with the precleared cell lysate at 4°C for 12 h. After incubation,
the lysate was centrifuged to pellet the IP matrix. The matrix was washed two
times with PBS and resuspended in 15 l of double-distilled H2O and 3 l 6
SDS loading dye. Samples were boiled for 5 m and resolved on a 10% poly-
acrylamide gel. Western blotting was used with anti-PITX2 antibody and horse-
radish peroxidase-conjugated rabbit ExactaCruz C reagent to detect immuno-
precipitated proteins.
RESULTS
Pitx2 binds to the Lef-1 promoter in vivo. The mouse Lef-1
promoter contains multiple Pitx2 binding sites (bicoid sites)
(Fig. 1A). ChIP analyses were done in LS-8 oral/dental epithe-
lial cells to demonstrate Pitx2 binding to the Lef-1 promoter
because the LS-8 cell line endogenously expresses Pitx2 and
Lef-1 (11, 22). A primer pair flanking the Pitx2 binding site
located at 779 to 784 in the proximal Lef-1 promoter pro-
duced a 381-bp product (Fig. 1A). Chromatin isolated from
cells prior to IP served as an input control. The primer set
amplified the Lef-1 promoter from chromatin input derived
from the LS-8 cell line (Fig. 1B, lane 4). A PCR was performed
without chromatin and with primers only as a negative control
(Fig. 1B, lane 3). Endogenous Pitx2 was bound to the Lef-1
promoter in vivo, as shown using PITX2 antibody and Lef-1
primers (Fig. 1B, lane 2). Normal rabbit IgG was used as a
control and did not immunoprecipitate the Lef-1 promoter
(Fig. 1B, lane 5). Furthermore, primers for an unrelated gene
did not amplify a product from the PITX2 antibody-immuno-
precipitated chromatin (Fig. 1B, lane 6). A second ChIP assay
was performed to demonstrate Pitx2 binding to a distal ele-
ment in the Lef-1 promoter. A primer pair flanking the Pitx2
binding site located at 5447 to 5452 in the distal Lef-1
promoter produced a 412-bp product (Fig. 1A). The assay was
performed as shown in Fig. 1B using different primers and with
the addition of the control primer PCR product from the
chromatin input to demonstrate that the control primers pro-
duced the correct product (Fig. 1C). All PCR products were
sequenced to confirm their identities.
The transcriptional activity of the 2.5-kb human LEF-1 pro-
moter is spatially restricted to the early bud stage and vestib-
ular lamina of developing teeth. During tooth morphogenesis,
LacZ expression was absent at the epithelial-thickening stage
of tooth formation in E11.5 embryos (Fig. 2A). However,
transgene expression was seen where the incisor and molar
teeth developed at E12.5 (Fig. 2B). Transgene expression dur-
ing molar tooth development was observed only in E12.5 em-
bryos, in which Lef-1 gene regulation has also been implicated
(32). However, molar expression of the LEF-1 promoter dis-
appeared in E13.5 embryos (Fig. 2C). Conversely, LEF-1 pro-
moter expression during incisor tooth development persisted
from E12.5 to E17.5 (Fig. 2B, C, E, and F), and higher mag-
nification revealed robust LacZ staining in the incisors (Fig.
2C, E, and F, insets). Transgene-negative littermates did not
express LacZ at any developmental time points (Fig. 2D and
data not shown). The transgenic reporter was also expressed in
the whisker follicles, demonstrating that the LEF-1 promoter
contains elements necessary for specific expression at sites
known for endogenous Lef-1 expression (Fig. 2C and E). Sec-
tions of mouse incisor tooth buds at E13.5 and E14.5 demon-
strated robust LacZ expression throughout the dental epithe-
lium of the tooth bud and developing cap stage and the dental
lamina (Fig. 2G and H).
Although expression of the 2.5-kb LEF-1 promoter over-
lapped with endogenous Lef-1 mRNA (Fig. 2I and J), no trans-
gene expression was detected in the mesenchyme during the
cap stage. This reflects a divergence from where the Lef-1
mRNA and protein are normally seen. These findings suggest
that the 2.5-kb LEF-1 promoter contains sufficient information
to regulate expression properly during the initial bud-forming
stage of tooth development and during the stages of vestibular-
lamina formation. Interestingly, this region of the promoter
was expressed only in epithelium-derived cell types of the den-
tal organ. Pitx2 expression is also restricted to the dental epi-
thelium and is not observed in the mesenchyme-derived cell
types (23). Expression restricted to only certain epithelial cell
types of the dental organ also suggests that diverse transcrip-
tional programs regulate different regions of the LEF-1 pro-
moter during tooth development. -Catenin was expressed in
the epithelium and condensing mesenchyme in tooth incisors
at E14.5 and was found to be both nuclear and cytoplasmic
(Fig. 2K to M).
Pitx2 and Lef-1 are coexpressed in the developing mouse
incisor. Pitx2 expression was detected in E12.5 incisors, while
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comparatively low levels of Lef-1 expression were observed at
the same time point (compare Fig. 3C to D). Pitx2 expression
increased by E14.5 in the incisors (Fig. 3E). Furthermore,
LacZ expression from the LEF-1 promoter in the transgenic
mouse was observed at E14.5, demonstrating specific expres-
sion of the human LEF-1 promoter in the mouse incisors (Fig.
3F). As controls, sense probes were used for Pitx2 and Lef-1
expression in E12.5 whole-mount embryos (Fig. 3A and B) and
did not give a signal.
PITX2 activates endogenous expression of the Lef-1 FL iso-
form in CHO cells. A tooth epithelial cell line, LS-8; a pluri-
potent cell line, C3H10T1/2; and CHO cell lysates were as-
sayed for endogenous Lef-1 protein by Western blotting. We
previously showed that the LS-8 and C3H10T1/2 cells endog-
enously express the 57-, 55-, and 39-kDa Lef-1 isoforms (11).
The Lef-1 FL isoform is produced from the Lef-1 P1 promoter,
and the N-terminally truncated Lef-1 N113 isoform is syn-
thesized from the Lef-1 P2 promoter in intron 2 (Fig. 4A) (30,
34). The 55- and 57-kDa Lef-1 products are produced from the
same P1 promoter and may arise from alternative splicing or
posttranslational modifications (30, 34, 45). However, CHO
cells endogenously express only the 39-kDa isoform (Fig. 4B).
PITX2 induced expression of the 57-kDa Lef-1 FL isoform in
CHO cells, which do not endogenously express Pitx2 (Fig. 4B).
Interestingly, an 60-kDa band recognized by the Lef-1 anti-
body was observed in the CHO cell lysates (Fig. 4B). This band
disappeared after PITX2 expression in CHO cells (Fig. 4B).
The nature of this band is unknown, and it has not been
previously reported. To confirm the expression of the 57-kDa
band in the Western blot, an RT-PCR assay was performed
using RNA isolated from PITX2-transfected CHO cells. The
short Lef-1 transcript was detected in both mock- and PITX2-
transfected cells (Fig. 4C, lanes 3 and 4). However, primers
that amplify the Lef-1 FL isoform did not produce a PCR
product from the mock-transfected cells but did detect the
Lef-1 FL transcript from the PITX2-transfected cells (Fig. 4C,
lanes 6 and 7). As a control, -actin primers detected equal
amounts of -actin transcripts from both mock- and PITX2-
transfected cells (Fig. 4B, lanes 9 and 10). All RT-PCR prod-
ucts were sequenced to confirm their identities. -Catenin is
highly expressed in both LS-8 and 10T1/2 cells, but relatively
low expression was observed in CHO cells (Fig. 4D). These
data suggest that cells expressing Pitx2 regulate endogenous
Lef-1 isoform expression.
FIG. 1. Pitx2 binds to the Lef-1 promoter in vivo. (A) Schematic of the mouse Lef-1 promoter, with the Pitx2 binding sites and locations of the
sense primers and the antisense primers indicated. (B) ChIP assays of the Lef-1 proximal promoter were performed using LS-8 cells. Lane 1
contains the 1-kb ladder, and lane 2 is the Pitx2 antibody (Ab)-immunoprecipitated chromatin amplified using the specific Lef-1 promoter primers
that produced the correct-size product of 381 bp. Lane 3 is Lef-1 primers only; lane 4 is the chromatin input using the Lef-1 promoter primers.
Lane 5 is the IP using normal rabbit IgG and Lef-1 primers, and lane 6 is the PITX2 Ab-immunoprecipitated chromatin amplified with primers
for an unrelated gene. (C) ChIP assays of the Lef-1 distal promoter were performed using LS-8 cells. All lanes are as in panel B, except for different
primer sets and lane 7 containing the PCR product with the control primers and chromatin input.
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PITX2 isoforms activate the LEF-1 promoter. PITX2A
and -C isoforms are expressed during dental morphogenesis.
CHO cells transfected with the PITX2 isoforms revealed dif-
ferences in their activations of the LEF-1 promoter (Fig. 5A).
PITX2A activated the LEF-1 promoter at 10-fold and
PITX2C at 18-fold (Fig. 5A). The active mutant -catenin
S37A construct and Lef-1 N113 did not activate the LEF-1
promoter, and cotransfection of both factors minimally acti-
vated LEF-1 (Fig. 5A). This was expected, as the Lef-1 N113
isoform does not contain the BD. -Catenin synergistically
activated the LEF-1 promoter in combination with PITX2A
and -C (Fig. 5A). PITX2A and -C isoforms synergistically
activated the LEF-1 promoter in concert with Lef-1 N113,
indicating that the BD is not required for this interaction with
PITX2A and -C (Fig. 5A). Cotransfection of PITX2A and -C
with Lef-1 N113 and -catenin resulted in a further synergis-
tic activation of the LEF-1 promoter (Fig. 5A).
The Lef-1 FL protein activated the LEF-1 promoter at low
levels, approximately fourfold, and at sevenfold in combination
with -catenin (Fig. 5B). -Catenin synergistically activated
the LEF-1 promoter in combination with PITX2A and -C (Fig.
5B). The synergistic activation of the Lef-1 FL isoform with
PITX2A and -C was similar to that of the Lef-1 N113 isoform
(Fig. 5B). Coexpression of PITX2 isoforms, Lef-1 FL, and
-catenin revealed increased synergistic activation (Fig. 5B).
Transfected cells expressed the PITX2 isoforms, the Lef-1
N113 and Lef-1 FL isoforms, and -catenin (Fig. 5C, D,
and E).
CHO cells were chosen, as they do not endogenously express
Pitx2 or the Lef-1 FL isoform and we could assay these activ-
ities independently of the response to endogenous activation.
However, we repeated these experiments in the LS-8 tooth
epithelial cell line, which endogenously expresses -catenin,
Lef-1, and Pitx2 isoforms (22). The relative differences in
transactivation between the PITX2 isoforms in the presence of
the various Lef-1 isoforms and/or -catenin were similar to
those of CHO cells (data not shown). These data support a
-catenin-independent Lef-1 interaction with PITX2 isoforms
that regulates the LEF-1 promoter and is not cell dependent.
Consistent with increased PITX2 transcriptional activation
by -catenin S37A (41), cells treated with LiCl increased
PITX2 activation of the LEF-1 promoter. LiCL is a potent
glycogen synthase kinase 3 inhibitor and inhibits -catenin
phosphorylation and stabilizes the pool of cellular -catenin
similarly to Wnt signaling (36). The Lef-1 N113 isoform was
used to determine if endogenous -catenin interaction with
Lef-1 was required for the synergistic activation of the LEF-1
promoter by PITX2. CHO cells were chosen for their low
FIG. 2. Expression of the LF-2700 transgenic LEF-1 promoter during tooth morphogenesis. (A to F) Whole-mount X-Gal staining of
transgenic (Tg) (A to C, E, and F) and nontransgenic (Tg) (D) littermates demonstrated LacZ transgene expression in incisors (i) and molars
(m) for the indicated developmental time points. The insets (c, e, and f) show enlargements of the boxed regions in the same panels of whole-mount
staining. (G and H) Parasagittal sections of whiskers of E13.5 and E14.5 embryos indicated the expression of LEF-1–LacZ in the dental lamina
and epithelium but not the mesenchyme of the tooth. (G and H) Propidium iodide staining of the sections corresponding to panels G (G) and
H (H). (I) In situ hybridization using a Lef-1–cRNA probe demonstrated Lef-1 expression in the dental epithelium and mesenchyme of an incisor
at the initiation of the cap stage (E14.5). (J) No signal was detected using a Lef-1 sense probe. (K, L, and M) Sagittal sections and immunohis-
tochemical assays of E14.5 mouse incisors using a -catenin antibody and DAB staining at 4, 10, and 20 magnifications, respectively. K, L,
and M) Control (secondary antibody only) sections corresponding to panels K, L, and M. The sections are not counterstained to reveal all areas
of -catenin staining. The incisor tooth bud is outlined. WF, whisker follicle; de, dental epithelium; oe, oral epithelium; ve, vestibular epithelium;
t, tongue; dm, dental mesenchyme.
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levels of endogenous -catenin and lack of Lef-1 FL or Pitx2
expression. LiCl treatment of CHO cells did not activate the
LEF-1 promoter in the presence of Lef-1 N113; however,
PITX2 transcriptional activation of the LEF-1 promoter in-
creased from 17-fold to 39-fold following LiCl treatment (data
not shown). Cells cotransfected with PITX2 and Lef-1 N113
and treated with LiCl revealed a dramatic increase in activa-
tion of the LEF-1 promoter, from 28-fold to 95-fold (data not
shown).
Mutation of the Lef-1 BD demonstrates a -catenin-inde-
pendent pathway for PITX2 activation. The Lef-1 FL protein
activity, in which the -catenin interaction was abolished by
specific mutations (Lef-1 M5), was compared to the Lef-1
N113 N-terminally truncated protein. Lef-1 M5 contains six
amino acid substitutions that disrupt the ability of the Lef-1 FL
protein to interact with -catenin (Fig. 6A) (28). Interestingly,
this construct activated the LEF-1 promoter 17-fold; how-
ever, the synergistic responses with PITX2 were similar for
both Lef-1 FL and Lef-1 M5 at 55-fold (Fig. 6B). Cotrans-
fection of -catenin, PITX2, and Lef-1 M5 resulted in 100-fold
activation of the LEF-1 promoter (Fig. 6B). Thus, Lef-1 N-
terminal residues do not affect its transcriptional activation
with PITX2, nor is the activation dependent on -catenin. A
Lef-1 deletion construct (Lef-1N-catenin) contains the
Lef-1 HMG domain and the armadillo repeat and can act as a
dominant active transcription factor (3). Lef-1N-catenin
activated the LEF-1 promoter18-fold (Fig. 6B). Lef-1N-
FIG. 3. Pitx2 and Lef-1 expression overlap in the developing tooth
incisor. (A and B) Whole-mount in situ hybridization using Pitx2c
sense probe (A) and Lef-1 sense probe (B) controls. (C and E) Whole-
mount in situ hybridization using a Pitx2c antisense cRNA probe
demonstrated Pitx2c mRNA expression in the mouse incisor (i) and
molar (m) teeth at E12.5 (C) and E14.5 (E), respectively. Teeth are
indicated by red arrows. (D) Lef-1 antisense in situ probe showing
Lef-1 expression in the mouse incisors (red arrows) and lip pad (lip,
white arrows) at E12.5. (F) A 2.5-kb LEF-1–LacZ transgenic mouse
showing LacZ staining of the mouse incisors (I, red arrows) and lip pad
(lip) at E14.5 (white arrows).
FIG. 4. PITX2 regulates endogenous Lef-1 expression. (A) Schematic of two Lef-1 isoforms. The Lef-1 FL isoform is produced from the P1
promoter and encodes proteins of 57 and 55 kDa. The Lef-1 N113 isoform is produced from the P2 promoter and encodes a protein of 39 kDa.
The Lef-1 endogenously expressed isoforms also contain a CAD and an HMG domain. (B) PITX2-transfected CHO cells express the 57-kDa Lef-1
FL isoform. Molecular mass markers are shown on the left. Lef-1 protein was detected using the Lef-1 antibody. (C) RT-PCR assay using RNA
isolated from either mock- or PITX2-transfected CHO cells. Mock- and PITX2-transfected CHO cells express the Lef-1 N113 transcript, while
only the PITX2-transfected cells express the Lef-1 FL transcript. -Actin transcripts are equally expressed in both mock- and PITX2-transfected
cells. (D) Expression of endogenous -catenin in LS-8, C3H10T1/2, and CHO cell lysates. Approximately 40 g of lysate was used in the -catenin
Western blot. Molecular weight markers are shown on the left.
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FIG. 5. PITX2 isoforms, -catenin, and Lef-1 synergistically activate the LEF-1 promoter in CHO cells. (A) CHO cells were transfected with
the LEF-1 2700 luciferase reporter gene (5 g). The cells were cotransfected with the CMV-PITX2A and -C isoforms and/or the CMV–Lef-1
N113 short isoform and/or CMV–-catenin S37A expression plasmids, or the CMV plasmid without PITX2, -catenin, or Lef-1 N113 () (2.5
g). (B) CHO cells were transfected as in panel A, except the Lef-1 FL expression plasmid was used in the experiments. To control for transfection
efficiency, all transfections included the SV-40 -galactosidase reporter (0.5 g). The cells were incubated for 24 h and then assayed for luciferase
and -galactosidase activities. The activities are shown as mean activation (n-fold) compared to the LEF-1 promoter plasmid without PITX2,
-catenin, or Lef-1 expression and normalized to -galactosidase activity (plus standard errors of the mean from five independent experiments for
panel A and from four experiments for panel B). The mean LEF-1 promoter luciferase activity with PITX2 expression was about 250,000 light units
per 15 g protein, and the -galactosidase activity was about 75,000 light units per 15 g protein. (C) Western blot of transfected PITX2 isoforms
in the CHO cell line using the PITX2 antibody. Whole-cell lysates from each cell line were prepared, and 20 g of protein was run on a 10%
SDS-polyacrylamide gel. The proteins were visualized using ECL reagents from Amersham. Pure PITX2 isoform proteins were used as a control
at 80 ng. (D) Western blot of transfected Lef-1 FL and Lef-1 N113 proteins from CHO cells using the same experimental procedure as for panel
C. Purified Lef-1 N113 protein was used as a control at 80 ng. The transfected Lef-1 N113 protein migrated slightly more slowly than the pure
protein due to the Myc-His tag on the transfected protein. The molecular weight markers are noted. (E) Transfected -catenin in LS-8 and CHO
cells; approximately 20 g of lysate was used in the -catenin Western blot.
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catenin synergistically activated the LEF-1 promoter in concert
with PITX2, but not at the high levels observed when all three
proteins were coexpressed (Fig. 6B). These data suggest that
the Lef-1 context-dependent activation domain (CAD) is re-
quired for its synergistic activation with PITX2 and that the
synergistic effect of Lef-1N-catenin with PITX2 was due to
the -catenin protein.
The Lef-1 CAD is required for PITX2 transcriptional syn-
ergy. Deletion of the Lef-1 N terminus, including the CAD, but
retaining the HMG domain (Lef-1 N295) resulted in a loss of
synergism with PITX2 in LS-8 cells (Fig. 7A and B). Further
deletion of the HMG domain in construct Lef-1 N363 also
resulted in a loss of synergism with PITX2 (Fig. 7A and B). A
C-terminal Lef-1 deletion removing only 34 C-terminal resi-
dues, Lef-1 N113-C34, did not synergistically activate the
LEF-1 promoter in combination with PITX2 (Fig. 7A and B).
Interestingly, deletion of the Lef-1 HMG domain, but leaving
the CAD domain intact (Lef-1 N113-C102), resulted in an
increased synergism with PITX2 at 24-fold (Fig. 7A and B).
Because the Lef-1 HMG domain is required for DNA binding,
the synergism of Lef-1 N113-C102 with PITX2 indicates
that Lef-1 DNA binding is not necessary for this interaction.
Furthermore, the Lef-1 HMG domain acts to repress the syn-
ergistic activation of the LEF-1 promoter by PITX2. Similar
results were observed using the PITX2C isoform and CHO cell
transfections (data not shown). Nuclear expression of the trun-
cated Lef-1 proteins in transfected cells has been reported
(reference 21 and data not shown).
PITX2 and Lef-1 FL physically interact. Co-IP experiments
detected interaction of the Lef-1 FL isoform with PITX2A in
CHO cells (Fig. 8). The Lef-1 antibody immunoprecipitated
the PITX2A–Lef-1 protein complex in transfected CHO cell
lysates (Fig. 8, lane 4). In mock-transfected cell lysates, the
Lef-1–PITX2A complex was not immunoprecipitated (Fig. 8,
lane 1). Cell lysates were directly analyzed by Western blotting
for PITX2 expression (Fig. 8, lanes 6 and 8). As a control, pure
PITX2 protein (75 ng) was also loaded onto the gel (Fig. 8,
lane 9). The transfected protein migrated slightly more slowly
in the gel due to a Myc-His tag on the protein.
Lef-1 contains two PITX2 binding domains. To determine
the locations of Lef-1 residues interacting with PITX2, GST–
Lef-1 deletion proteins were isolated, immobilized, and incu-
bated with purified PITX2C protein. Our GST pull-down ex-
periments demonstrated that PITX2 can bind to the Lef-1
CAD and C-terminal flanking residues (Lef-1 N113-C102)
to comprise PITX2 binding domain no. 1 (Fig. 9A and B). A
second PITX2 binding domain (no. 2) is located in the C-
terminal tail of Lef-1 and contains the last 34 residues (Lef-1
N363) (Fig. 9A and B). A strong interaction occurred with
the Lef-1 N113-C34 protein containing the distal HMG
domain; however, in multiple experiments, PITX2 consistently
bound the Lef-1 N113-C102 protein. PITX2C does not bind
to the BD (GST–Lef-1 BD) located at the Lef-1 N terminus
(Fig. 9B). The purified Lef-1 proteins used in the GST pull-
down experiments are shown in the Coomassie blue-stained gel
(Fig. 9C). We have previously reported that the C-terminal tail
of PITX2 interacts with Lef-1 (41). All PITX2 isoforms contain
identical C-terminal tails, and all can interact with Lef-1.
-Catenin interacts with the PITX2 homeodomain. To de-
termine the PITX2 -catenin interaction site, GST-PITX2 and
GST-PITX2 deletion proteins were immobilized on Sepharose
beads and incubated with the -catenin protein. -Catenin
bound to the PITX2 full-length protein, the N-terminally trun-
cated PITX2 N38 protein, and the C-terminally truncated
PITX2 C173 protein (Fig. 10A and B). However, it did not
FIG. 6. -Catenin induces LEF-1 promoter activation by PITX2 independently of its interaction with Lef-1. (A) Schematic of -catenin (S37A),
Lef-1 FL, Lef-1 M5, and Lef-1N-CatN expression constructs. The M5 mutations in Lef-1 M5 are denoted by an X, which indicates the inability
of this protein to interact with -catenin. (B) CHO cells were transfected with the 2.5-kb LEF-1 luciferase reporter gene (5 g). The cells were
cotransfected with the CMV-PITX2A and/or CMV–Lef-1 FL, CMV–Lef-1 M5, and/or CMV–-catenin; Lef-1N-catenin expression plasmids;
or the CMV plasmid without PITX2, -catenin, or Lef-1 () (2.5 g). To control for transfection efficiency, all transfections included the SV-40
-galactosidase reporter (0.5 g). The activities are shown as mean activation (n-fold) compared to the LEF-1 promoter plasmid without PITX2,
-catenin, or Lef-1 expression and normalized to -galactosidase activity (plus standard errors of the mean from five independent experiments).
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bind to the PITX2 C173 protein comprising the complete
PITX2 C-terminal tail (Fig. 10A,B). Thus, -catenin interacts
with the homeodomain of PITX2 separately from the Lef-1
interaction domain in the PITX2 C-terminal tail.
-Catenin and Lef-1 interact independently with PITX2. To
demonstrate independent and simultaneous binding of both
-catenin and Lef-1 to PITX2, purified -catenin and Lef-1
N113 were incubated with immobilized GST-PITX2 home-
odomain and GST-PITX2 C173 (Fig. 11A). Reactions were
carried out with both -catenin and Lef-1 N113 in the bind-
ing reactions, and after processing, the reaction mixtures were
split and one reaction mixture was probed with -catenin an-
tibody and the other with Lef-1 antibody. The Lef-1 N113
protein was used, as it does not contain the BD and does not
interact with -catenin. -Catenin specifically interacted with
the PITX2 homeodomain, and Lef-1 interacted with the
PITX2 C terminus (Fig. 11B and C). Our results indicate that
Lef-1 and -catenin interact independently and simultaneously
with the PITX2 protein through binding to separate protein
interaction sites on the PITX2 protein. These results corrob-
orate the transcriptional synergism observed when PITX2,
Lef-1, and -catenin are coexpressed.
DISCUSSION
Lef-1 expression is characterized by the production of sev-
eral isoforms, and Lef-1 transcripts arise through alternative
FIG. 7. The Lef-1 activation domain is required for synergism with PITX2. (A) Schematic of the Lef-1 deletion clones used to assay the
synergistic response with PITX2. (B) LS-8 cells were transfected with the LEF-1 2700 luciferase reporter gene (5 g). The cells were cotransfected
with the CMV-PITX2A and/or CMV–Lef-1 FL, –Lef-1 N113, and Lef-1 truncated expression plasmids or the CMV plasmid without PITX2 or
Lef-1 () (2.5 g). The transfections were performed as described in the legend to Fig. 5.
FIG. 8. Lef-1 and PITX2 physically interact. Lef-1 and/or
PITX2A expression plasmids (2.5 g) were transfected into CHO
cells and incubated for 24 h. Cells were harvested and lysed, and the
Lef-1–PITX2A protein complex was immunoprecipitated using the
Lef-1 antibody. The immunoprecipitated complexes were resolved
on a 10% polyacrylamide gel and transferred to a PVDF filter, and
Western blotting was done using the PITX2 antibody. Lane 1 is the
mock-transfected cell lysate IP, lane 2 is the PITX2-transfected IP,
lane 3 is the Lef-1 FL-transfected IP, and lane 4 is the Lef-1 FL- and
PITX2-cotransfected IP. Input controls are shown in lanes 5 to 8.
As a molecular weight control, 75 ng of purified PITX2A protein
was immunoblotted (lane 9). The transfected PITX2 migrated
slightly more slowly due to the presence of a C-terminal Myc/His
tag on the mammalian expression plasmids. Transfected Lef-1 is
expressed in CHO cells, and a representative lysate is shown in Fig.
5E. Molecular weight markers are shown between lanes 4 and 5.
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splicing and different promoters (8, 18, 26, 27, 34). The full-
length Lef-1 transcript contains a large 5 untranslated region
synthesized using a separate P1 promoter and utilizes a cap-
independent mechanism for translation of the full-length Lef-1
containing the BD (30, 34). This Lef-1 activity is countered by
the expression of a truncated Lef-1 protein that lacks the BD
and can compete for binding to Wnt target genes. The shorter
Lef-1 isoform is produced from a second (P2) promoter lo-
cated in the second intron of the LEF-1 locus (27, 30, 34).
Recent studies have shown that the LEF-1 promoter is tran-
scriptionally responsive to Wnt/Tcf/-catenin induction (12,
18, 34).
PITX2 and Lef-1 interact independently of -catenin.
PITX2A and -C isoforms synergistically activated the LEF-1
promoter in concert with -catenin. Because coexpression of
the Lef-1 N113 isoform with PITX2A and C isoforms and
-catenin resulted in further synergistic activation, these re-
sults suggested that Lef-1 interacts with PITX2 independently
of -catenin. Furthermore, LiCl treatment of transfected cells
dramatically increased PITX2 transcriptional activation of the
LEF-1 promoter in the absence of Lef-1 (data not shown).
A Lef-1 interaction with PITX2 independent of -catenin
was further characterized using the Lef-1 M5 BD mutant.
-Catenin expression resulted in a synergistic activation of the
LEF-1 promoter when cotransfected with PITX2 and Lef-1
M5. Thus, the BD of Lef-1 is not required for its interaction
with PITX2 or for the synergistic activation of PITX2 with
-catenin.
Induction of the LEF-1 promoter in epithelial compart-
ments during tooth organogenesis. LEF-1 promoter expres-
sion in incisor teeth was limited to epithelial cells of the form-
ing tooth bud and vestibular lamina in our studies using the
2.5-kb human LEF-1 promoter. These findings suggest that
regions contained within the 2.5-kb promoter allow proper
regulation of gene expression in a subset of epithelial, but not
mesenchymal, cells involved in tooth morphogenesis. The re-
sponsiveness of the 2.5-kb LEF-1 promoter segment to Wnt
signals in vitro is also consistent with Wnt10b expression at
FIG. 9. PITX2 binds to two regions of the Lef-1 protein. (A) Schematic of the Lef-1 deletion proteins used in the GST pull-down assays. The
locations of the two PITX2 interaction regions of Lef-1 are shown bracketed by lines and designated PITX2 binding domains (BD) 1 and 2.
(B) GST–Lef-1 and truncated Lef-1 protein pull-down assay with bacterially expressed and purified PITX2C protein (100 ng). PITX2 binds to the
Lef-1 N295 protein, as well as the last 34 residues of the Lef-1 C-terminal tail (GST–Lef-1 N363). This region is termed PITX2 BD 2. PITX2
binds to a region containing the CAD and 3 flanking residues (Lef-1 N113-C102) and is termed PITX2 BD 1. As a control, GST beads were
incubated with purified PITX2 to demonstrate the specificity of PITX2 binding to the GST–Lef-1 fusion proteins. PITX2 does not bind to the Lef-1
N-terminal BD (GST–Lef-1 BD). (C) Coomassie blue-stained gel of the purified Lef-1 proteins used in the binding assays. An asterisk denotes
the proteins. Molecular weight markers are located on the left of the gels.
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early stages of tooth bud formation as an inductive signal for
the Lef-1 promoter (10).
PITX2 induces Lef-1 isoform-specific expression. The Lef-1
FL isoform (57 kDa) was specifically synthesized by the
action of PITX2 in CHO cells. The Lef-1 FL isoform cor-
relates with PITX2 activation of the Lef-1 57-kDa isoform
from the P1 promoter (34). The increase in Lef-1 FL ex-
pression by PITX2 may result in a cell-proliferative effect.
The Lef-1 FL isoform has been termed growth promoting
because it is expressed during cell growth in undifferenti-
ated, mitotically active cells. Furthermore, this Lef-1 iso-
form can interact with -catenin and may stabilize nuclear
-catenin and allow increased Lef-1 and PITX2 transcrip-
tional activity. Because PITX2 is required for early devel-
opmental events that are characterized by cell division, dif-
ferentiation, and migration, the activation of the Lef-1 FL
isoform could be essential for these functions. The shorter
Lef-1 polypeptides could function as constitutive transcrip-
tional repressors or competitive inhibitors of Wnt signaling
by binding to Wnt-responsive elements in target genes. This
would then disrupt -catenin access and constitutively in-
hibit transcription by recruiting a repressor, and thus, it has
been termed growth suppressing (6, 26, 34). However,
PITX2 can interact with either Lef-1 isoform to synergisti-
cally activate transcription, which would inhibit the negative
action by the Lef-1 short isoform. These interactions could
play major roles during embryogenesis and in certain types
of cancer.
PITX2 interacts with two domains of the Lef-1 protein. The
Lef-1 amino terminus contains the BD involved in Wnt
signaling (4). The CAD (7, 21) and a region flanking the
CAD are required for association with the Groucho core-
pressor and histone deacetylase (5). The C-terminal HMG
domain is involved in DNA binding (20), and two regions
within the HMG domain mediate the interaction with Smad
factors (33). Two regions of Lef-1 were found to interact
with Smad3 in the HMG domain. Our data suggest that two
regions of Lef-1 interact with PITX2: the C-terminal region
of the HMG domain containing 30 amino acids (Lef-1
N363), which corresponds to the Smad3 MH1 binding do-
main, and a second region containing the CAD and flanking
sequences (Lef-1 N113-C102). A previous report demon-
FIG. 10. -Catenin interacts with the PITX2 homeodomain.
(A) Schematic of the PITX2 deletion proteins used in the GST pull-
down assays. HD, homeodomain; OAR, Otp and Aristaless domain.
(B) GST-PITX2A and truncated PITX2A protein pull-down assay
with bacterially expressed and purified -catenin protein (50 ng). To
demonstrate -catenin binding to PITX2, -catenin was incubated
with several N-terminally and C-terminally truncated GST-PITX2 pro-
teins. -Catenin bound to the PITX2A, PITX2A N38, and PITX2A
C173 proteins. -Catenin did not bind to the PITX2A C173 C-
terminal tail. As a control, GST beads were incubated with purified
PITX2 to demonstrate the specificity of PITX2 binding to the GST–
Lef-1 fusion proteins. -Catenin binds to the PITX2 homeodomian.
FIG. 11. Lef-1 and -catenin bind independently and simultaneously to PITX2. (A) Schematic of the GST-PITX2 fusion proteins used in the
GST pull-down assay. HD, homeodomain; OAR, Otp and Aristaless domain. (B) Lef-1 N113 and -catenin proteins (85 ng) were incubated
together with the immobilized GST-PITX2 constructs. -Catenin bound to immobilized GST-PITX2 HD (homeodomain) but not to the
GST-PITX2 C173 (C-terminal tail). (C) Lef-1 bound to immobilized GST-PITX2 C173 but not to the GST-PITX2 HD. Thus, -catenin and Lef-1
bind simultaneously to different PITX2 residues.
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strated that Lef-1 FL can synergize with Smad4 in response
to -catenin activation to activate the Msx2 promoter (29).
Furthermore, Dlx2 can interact with Lef-1 through these
sites, which increases the transcriptional activity of Dlx2,
similar to PITX2 (11). Competition between factors for
these sites could add to the complexity of Lef-1 transcrip-
tional activity.
Wnt signaling and -catenin regulate PITX2 transcrip-
tional activity. -Catenin is required for normal tooth devel-
opment and is expressed in the dental epithelium in an
overlapping fashion with Pitx2 and Lef-1 (17). Our data dem-
onstrate a mechanism for Wnt signaling in the transcriptional
activity of PITX2. We speculate that -catenin displaces an
inhibitory factor or complex that allows PITX2 to become
active. A Gal4-Pitx2 fusion protein demonstrated repressor
activity, and it was proposed that -catenin acts in Pitx2 dere-
pression (31).
-Catenin interacts with the homeodomain of PITX2, and
Lef-1 interacts with the PITX2 C-terminal tail. These sep-
arate interactions have a combinatorial/synergistic effect on
the transcriptional properties of PITX2. The Lef-1 FL or the
Lef-1 N113 isoform can interact with PITX2 indepen-
dently of -catenin, and -catenin can interact with PITX2
independently of Lef-1. We propose a model in which
-catenin can interact with PITX2, and depending on the
Lef-1 isoform interacting with PITX2, -catenin may be able
to directly interact with the Lef-1 FL isoform while com-
plexed with PITX2 to activate gene expression (Fig. 12).
Therefore, -catenin interacting with the PITX2 homeodo-
main or Lef-1 interacting with the PITX2 C-terminal tail
would independently increase PITX2 transcriptional activ-
ity. However, when both -catenin and either Lef-1 isoform
are present, they would form a potent PITX2 transcriptional
complex (Fig. 12). The activation of Lef-1 expression would
then provide a feedback mechanism for continued Lef-1
interaction with PITX2 to continuously drive Lef-1 FL ex-
pression.
Interestingly, a recent report has demonstrated a role for
FIG. 12. Model for PITX2-independent binding of -catenin and Lef-1 to increase PITX2 transcriptional activity. Depicted is PITX2 protein
binding to DNA; Wnt signaling stabilizes -catenin, which is translocated to the nucleus and interacts with PITX2 to synergistically activate the
LEF-1 P1 promoter. -Catenin interacts with PITX2 through its homeodomain (HD). Nuclear -catenin and Lef-1 FL interact with PITX2 and
may also interact with each other through the Lef-1 BD. Alternatively, -catenin and Lef-1 N113 interact with PITX2 but not with each other;
however, both complexes yield increased synergistic activation of the LEF-1 P1 promoter. Lef-1 interacts with PITX2 through the C-terminal tail.
PITX2 interacts with Lef-1 through two sites C-terminal to the BD and may allow Lef-1 and -catenin to interact when complexed to PITX2.
This complex allows PITX2 to be a highly active transcription factor in response to Wnt signaling and Lef-1 expression. The 10 identified
phosphorylation sites in the PITX2 protein are denoted by “P.” It has been shown that phosphorylation of PITX2 facilitates DNA binding and
protein interactions (16).
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Lef-1 in the survival of dental epithelial cells during tooth
development (40). In Lef-1-null mutant mice, the dental
epithelium underwent increased apoptosis and subtle
changes in cell proliferation. In Pitx2-null mutant mice,
tooth development is arrested at an earlier stage than in
Lef-1 mutants, and Pitx2 mutant mice have cell proliferation
and migration defects associated with defective tooth mor-
phogenesis (37). Thus, the differential activation of Lef-1
isoforms may play a role in the ability of PITX2 to regulate
cell migration and/or proliferation. PITX2 activation of the
LEF-1 promoter correlates with the temporal and spatial
expression patterns of these two factors in the dental epi-
thelium.
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